Research Article | Open Access
Sakuko Ueshima, Hisashi Muramatsu, Takanori Nakajima, Hiroaki Yamamoto, Shin-ichiro Kato, Haruo Misono, Shinji Nagata, "Identification, Cloning, and Characterization of l-Phenylserine Dehydrogenase from Pseudomonas syringae NK-15", Enzyme Research, vol. 2010, Article ID 597010, 10 pages, 2010. https://doi.org/10.4061/2010/597010
Identification, Cloning, and Characterization of l-Phenylserine Dehydrogenase from Pseudomonas syringae NK-15
The gene encoding D-phenylserine dehydrogenase from Pseudomonas syringae NK-15 was identified, and a 9,246-bp nucleotide sequence containing the gene was sequenced. Six ORFs were confirmed in the sequenced region, four of which were predicted to form an operon. A homology search of each ORF predicted that orf3 encoded L-phenylserine dehydrogenase. Hence, orf3 was cloned and overexpressed in Escherichia coli cells and recombinant ORF3 was purified to homogeneity and characterized. The purified ORF3 enzyme showed L-phenylserine dehydrogenase activity. The enzymological properties and primary structure of L-phenylserine dehydrogenase (ORF3) were quite different from those of D-phenylserine dehydrogenase previously reported. L-Phenylserine dehydrogenase catalyzed the -dependent oxidation of the -hydroxyl group of L--phenylserine. L-Phenylserine and L-threo-(2-thienyl)serine were good substrates for L-phenylserine dehydrogenase. The genes encoding L-phenylserine dehydrogenase and D-phenylserine dehydrogenase, which is induced by phenylserine, are located in a single operon. The reaction products of both enzymatic reactions were 2-aminoacetophenone and .
3-Hydroxy-2-amino acids are components of many bioactive molecules, such as antibiotics and immunosuppressants [1–9] and a drug for Parkinson’s disease therapy . Therefore, enzymatic synthesis of 3-hydroxy-2-amino acids with D- and L-threonine aldolases has been performed extensively [1, 2, 4–9]. -Phenylserine (2-amino-3-hydroxy-3-phenylpropanoic acid), which exists as four stereoisomers, is one of the physiologically important 3-hydroxy-2-amino acids [11–13]. However, until recently, little was known about phenylserine biosynthetic and degradation pathways. To elucidate metabolic processes involving phenylserine, we have attempted to obtain enzymes physiologically acting on phenylserine. Previously, we reported the molecular characteristics of inducible pyridoxal 5’-phosphate (PLP)-dependent phenylserine aldolase , PLP-dependent phenylserine dehydratase , and inducible NADP+-dependent D-phenylserine dehydrogenase (Scheme 1) . During the identification of the gene encoding D-phenylserine dehydrogenase, we found the gene encoding L-phenylserine dehydrogenase in the same operon. In this paper, we report the identification and cloning of the genes encoding D-phenylserine dehydrogenase and L-phenylserine dehydrogenase. Moreover, the enzymological properties of L-phenylserine dehydrogenase (Scheme 1) overexpressed in Escherichia coli are described.
2. Materials and Methods
D-threo--Phenylserine was a gift from Mr. Teruyuki Nikaido, Daicel Chemical Industries (Hyogo, Japan). Polypepton was from Nihon Pharmaceutical (Tokyo, Japan). NAD+, NADP+, yeast extract, and molecular-weight marker-proteins for gel filtration were from Oriental Yeast (Tokyo, Japan). Restriction enzymes and kits for genetic manipulation were from Takara Shuzo (Kyoto, Japan), Toyobo (Osaka, Japan), and New England Biolabs (Beverly, MA). All other reagents were of analytical grade from Sigma (St. Louis, MO), Nacalai Tesque (Kyoto, Japan), and Wako Pure Chemical Industries (Osaka, Japan).
Pseudomonas syringae NK-15 was cultivated at in a medium containing 0.5% DL-threo--phenylserine, 1.5% polypepton, 0.2% K2HPO4, 0.2% KH2PO4, 0.2% NaCl, 0.01% MgSO4·7H2O, and 0.01% yeast extract (pH 7.2) with reciprocal shaking .
2.3. Determination of Internal Amino Acid Sequence
Purified D-phenylserine dehydrogenase, prepared as previously described , was lyophilized and suspended in 8 M urea. After incubation for 1 hour at , the enzyme was digested with lysyl endopeptidase for 15 hours at . The resultant peptides were separated on a Shimadzu HPLC system equipped with a YMC-Pack C4 column ( mm, YMC Co., Kyoto, Japan) using a solvent system of 0.1% trifluoroacetic acid (solvent A) and acetonitrile containing 0.07% trifluoroacetic acid (solvent B). A 90-min linear gradient from 5 to 50% solvent B was used to elute peptides at a flow rate of 1.0 ml/min. The absorbance at 210 nm of the effluent was continuously monitored. The internal amino acid sequence of D-phenylserine dehydrogenase was determined using an automated protein sequencer (Perkin Elmer, Wellesley, MA).
2.4. Identification of the Gene Encoding D-Phenylserine Dehydrogenase and Gene Organization
Based on the N-terminal amino acid sequence of D-phenylserine dehydrogenase, determined as described previously , and the internal amino acid sequence of the enzyme determined in this work, inverse PCR was performed to identify the gene encoding D-phenylserine dehydrogenase. PCR products were sequenced with an Applied Biosystems 373A DNA sequencer and a DNA sequencing kit (ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction Kit). Inverse PCR was also used to determine the nucleotide sequence of the regions upstream and downstream of the D-phenylserine dehydrogenase gene.
2.5. Cloning and Expression of the Gene Encoding D-Phenylserine Dehydrogenase and the Orf3 Gene in Escherichia coli
Chromosomal DNA was prepared from P. syringae NK-15 by the method of Saito and Miura . A DNA fragment containing the gene encoding D-phenylserine dehydrogenase was amplified by PCR with Ex Taq DNA polymerase (Takara Shuzo, Kyoto, Japan) using a sense primer containing an EcoRI site (- GCGGAATTCGAATCCGCCAACCCACGCCAAGGAATAACGCA -) and an antisense primer containing a PstI site (- GCGAAGCTTCTGCAGCAAGCAGCGCTCACGTCGAAGCGCACA-). The amplified DNA fragment was ligated into the EcoRI-PstI site of pUC18. The resultant plasmid, pUPsDH, was introduced into E. coli JM109 to provide recombinant D-phenylserine dehydrogenase. E. coli JM109 carrying pUPsDH was cultivated in LB medium containing 50 g/ml ampicillin and 0.1 mM isopropyl--D-thiogalactopyranoside (IPTG) at for 20 hours. A DNA fragment containing the orf3 gene was amplified using a sense primer containing an EcoRI site and the ATG start codon (-GGGAATTCAGGAAACAGACCATGAGTTTTCCGGTTTGTCTCGTCA -) and an antisense primer containing a HindIII site (-GGAAGCTTATGTGTTGAGCAGCAGCCCGxTTCTCGATCG). The amplified DNA fragment was ligated into the EcoRI-HindIII site of pSE420D (Daicel Chemical Industries, Osaka, Japan) . The resultant plasmid, pSORF3, was deposited in the International Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology (Ibaraki, Japan) under accession number FERM-P-20287. To obtain recombinant ORF3, E. coli JM109 carrying pSORF3 was cultivated in LB medium containing 50 g/ml ampicillin and 0.1 mM IPTG at for 16 hours.
2.6. Purification of the orf3 Gene Product
The standard buffer used throughout purification was 10 mM potassium phosphate buffer (pH 8.0), and all operations were done at . Cultured E. coli cells expressing ORF3 were harvested by centrifugation, resuspended in 0.1 M potassium phosphate buffer (pH 8.0) containing 0.02% 2-mercaptoethanol (2-ME) and 2 mM phenylmethylsulfonyl fluoride (PMSF), and disrupted using a Micro Smash MS-100 (TOMY, Tokyo, Japan). After centrifugation, the supernatant was fractionated by ammonium sulfate precipitation (0–50% saturation). The enzyme-containing fraction was resuspended in 0.1 M potassium phosphate buffer (pH 8.0) containing 0.02% 2-ME and 2 mM PMSF, and dialyzed against the same buffer. The enzyme fraction was applied to a Q-Sepharose FF column (Pharmacia, Columbus, OH) equilibrated with the standard buffer containing 0.01% 2-ME. The enzyme was eluted with a linear gradient of 0–0.5 M NaCl in the same buffer. The enzyme fractions were collected, concentrated, dialyzed against the standard buffer containing 0.01% 2-ME and 20% saturated ammonium sulfate, and centrifuged. The supernatant was applied to a Phenyl superose HP 26/10 column (Pharmacia, Columbus, OH) equilibrated with the standard buffer containing 0.01% 2-ME and 30% saturated ammonium sulfate. The enzyme was eluted with a linear gradient of 20–0% saturated ammonium sulfate in the buffer. The enzyme fractions were collected, concentrated and dialyzed against the standard buffer containing 0.01% 2-ME. The final preparation of the enzyme was stored at until use.
2.7. Enzyme Assay
L-Phenylserine dehydrogenase activity was assayed by monitoring the increase in absorbance at 340 nm due to the production of NADH at in a 1-ml reaction mixture containing 20 mM DL-threo--phenylserine and NAD+ in 0.2 M Glycine-KCl-KOH buffer (pH 10.5). D-Phenylserine dehydrogenase activity was determined as previously described .
2.8. Thin Layer Chromatography (TLC) Analysis
A reaction solution containing 40 mM DL-threo--phenylserine, NAD+, and 0.3 mg/ml purified ORF3 in 0.1 M Glycine-KCl-KOH buffer (pH 10.5) was incubated overnight at . The reaction solution, DL-threo--phenylserine, and 2-aminoacetophenone were applied to a TLC plate, Kieselgel 60 F254 (Merck, Darmstadt, Germany). The chromatogram was developed using n-butanol-acetic acid-water (4:1:1, by vol.. The spots of DL-threo-phenylserine and 2-aminoacetophenone were detected by spraying the TLC plate with 1.5% ninhydrin solution in acetone-ethanol (7:3, by vol. and incubating at until color developed.
2.9. Analytical Methods for Enzyme
Protein concentration was determined using a Protein assay kit (Bio-Rad, Hercules, CA) with bovine serum albumin as standard. The molecular mass of the subunit of L-phenylserine dehydrogenase was examined by SDS-PAGE using Protein Markers for SDS-PAGE (Nacalai Tesque, Kyoto, Japan). The molecular mass of native L-phenylserine dehydrogenase was estimated by HPLC on a TSK-GEL G3000SW column (0.) operating at room temperature. The column was eluted with 0.1 M potassium phosphate buffer (pH 7.0) containing 0.2 M NaCl at a flow rate of 0.7 ml/min. Amino acid sequences were obtained from PubMed at NCBI (http://www.ncbi.nlm.nih.gov/). A homology search was performed using the BLAST program  at GenomeNet (http://www.genome.ad.jp/). Multiple alignments were obtained with the ClustalW program  at GenomeNet (http://www.genome.ad.jp/).
2.10. Nucleotide Sequence Accession Number
The nucleotide sequence data have been deposited in the DDBJ/EMBL/GenBank nucleotide sequence databases under accession number AB499092.
3.1. Identification of a Gene Encoding D-Phenylserine Dehydrogenase
Purified D-phenylserine dehydrogenase was obtained as previously described . The enzyme was digested with lysyl endopeptidase, and the peptide products were purified by reversed-phase HPLC. The amino acid sequences of only two internal peptides could be determined (Figure 1). Based on the N-terminal amino-acid sequence and the internal amino acid sequences determined, an 897-bp nucleotide sequence was identified as the gene encoding D-phenylserine dehydrogenase (Figure 1). A crude extract of E. coli JM109 transformed with the pUPsDH expression vector containing the gene showed D-phenylserine dehydrogenase activity (33 U/mg), while that of wild-type E. coli JM109 was inactive.
3.2. Gene Organization of Regions Upstream and Downstream of the D-Phenylserine Dehydrogenase Gene
To determine the nucleotide sequence of upstream and downstream regions of the gene encoding D-phenylserine dehydrogenase, inverse PCR was carried out. As a result, a 9,246-bp nucleotide sequence containing at least six open reading frames (ORFs) was determined (Figure 2). The transcriptional directions of orf1 and orf6 are opposite to those of the four other ORFs. Postulated promoter and terminator sequences are located immediately upstream of orf2 and downstream of D-phenylserine dehydrogenase encoding orf5, respectively. These observations suggest that orf2, orf3, orf4, and orf5 may form an operon.
orf1 encodes a protein of 320 amino acids that is similar to amino acid sequences of putative LysR-type transcriptional regulators. Thus, orf1 probably plays a role in the regulation of transcription of the operon. orf2 encodes a protein of 436 amino acids that shows sequence similarity to putative major facilitator superfamily (MFS) transporters. orf4 encodes a protein of 579 amino acids that is similar to amino acid sequences of putative dihydroxy acid dehydratases (ilvD). The ilvD gene has previously been identified in the ilv operon involved in branched-chain amino acids biosynthesis [21–23]; however, the operon containing the gene for D-phenylserine dehydrogenase did not contain other genes related to branched-chain amino acids metabolism. orf5 encodes D-phenylserine dehydrogenase, which was previously characterized . orf6 encoded a protein of 520 amino acids that showed high similarity with amino acid sequences of putative ABC peptide transporters.
orf3 encodes a protein of 259 amino acids that shares 37% identity with ketoreductase (RED2) from Streptomyces violaceoruber Tü22  and 28% identity with 1,3,8-trihydroxynaphthalene reductase (3HNR) from Magnaporthe grisea (Figure 4) [25, 26]. The amino acid sequence of ORF3 also shows high similarity to that of putative short chain dehydrogenases and putative 3-oxoacyl-(acyl-carrier protein) reductases and 24% identity with serine dehydrogenase from Agrobacterium tumefaciens ICR 1600 . A common GXXXGXG sequence, which is characteristic of an NAD(P)-binding site conserved in serine dehydrogenase and its homologs , was found in the N-terminal region of ORF3. For these reasons, we assumed that ORF3 has dehydrogenase activity, and considered that 3-hydroxy amino acids were likely to serve as a substrate for the enzyme, so cloning of orf3 was done.
3.3. Purification of L-Phenylserine Dehydrogenase (ORF3)
ORF3 was purified to homogeneity from the recombinant E. coli JM109 cell carrying pSORF3. ORF3 has a calculated molecular mass of 27498.3 Da. The purified protein gave a single band with a molecular mass of 27 kDa on SDS-PAGE. The molecular mass of the native protein was determined to be 98 kDa by gel filtration. Because the elution of ORF3 was likely slightly slowed by nonspecific hydrophobic and ionic interactions between ORF3 and the gel filtration resin, the apparent molecular mass of the protein was most likely an underestimate. Therefore, ORF3 probably consists of four identical subunits. A summary of the specific activity and recovery of ORF3 during purification is shown in Table 1.
|The enzyme activity was measured with 20 mM DL-threo--phenylserine and 2.5 mM NAD+ in 0.2 M glycine-KCl-KOH buffer (pH 10.5) at .|
3.4. Properties of L-Phenylserine Dehydrogenase (ORF3)
The molecular characteristics of the enzyme are shown in Tables 2, 3, and 4. The enzyme was significantly inhibited by 0.05 mM p-chloromercuribenzoate and 0.01 mM HgCl2. However, thiol reagents, such as N-ethylmaleimide and iodoacetamide, the chelating agent EDTA, and bivalent metal cations did not affect the enzyme (Table 2). The enzyme acted in an NAD+-dependent way on DL-threo--phenylserine but not on D-threo--phenylserine. Because we could not obtain pure L-threo--phenylserine, we were unable to perform enzyme assays with L-threo--phenylserine as a substrate. However, the data we obtained indicate that the enzyme showed activity towards only the L-form. The enzyme also acted on DL-erythro--phenylserine and DL-threo-(2-thienyl)serine. Pure L-forms of these compounds are also unavailable, but the enzyme likely acted on only the L-forms of erythro--phenylserine and threo-(2-thienyl)serine. Other amino acids tested did not serve as a substrate. The enzyme showed weak activity toward (S)-phenylethanol (Table 3). TLC analysis revealed that the enzyme converted L--phenylserine (Rf = 0.52) into 2-aminoacetophenone (Rf= 0.63). Therefore, we considered that the enzyme catalyzed the oxidation of the -hydroxyl group of L--phenylserine and that the reaction product, L--amino--keto--phenylpropionate, spontaneously decarboxylated to form 2-aminoacetophenone (Scheme 2). The enzyme preferred NAD+ to NADP+ as a coenzyme. The enzyme showed maximal activity at pH 11.2 and was stable between pH 6.1 and 11.2 at . The enzyme was stable at temperatures lower than for at least 10 minutes and showed the highest activity at (Table 4). The apparent values for DL-threo--phenylserine and NAD+ were 59 and 2.1 mM, respectively.
|L-Phenylserine dehydrogenase activity was determined in reaction mixtures containing the indicated additive, 20 mM DL-threo--phenylserine and 2.5 mM NAD+ in 0.2 M glycine-KCl-KOH buffer (pH 10.5) at . |
|L-Phenylserine dehydrogenase activity was determined in reaction mixtures containing 10 or 20 mM substrate, as indicated, and 1.0 mM NAD+ in 0.2 M glycine-KCl-KOH buffer (pH 10.5) at .|
The enzymological properties of D-phenylserine dehydrogenase have already been reported , but the nucleotide sequence of the gene encoding D-phenylserine dehydrogenase was determined in this work. The amino acid sequence of D-phenylserine dehydrogenase shares 24% identity with 3-hydroxyisobutyrate dehydrogenase (TTHA0237) from Thermus thermophilus HB8  and 24% identity with a possible 3-hydroxyisobutyrate dehydrogenase (PA0743) from Pseudomonas aeruginosa PAO1. An alignment of the amino acid sequences of D-phenylserine dehydrogenase, TTHA0237, and PA0743 is shown in Figure 3. Many NAD/NADP-dependent dehydrogenases contain the Rossmann fold for nucleotide binding; the pyrophosphate group interacts with the GXGXX(G/A) motif found in the Rossmann fold . This characteristic glycine-rich fingerprint motif was highly conserved in the N-termini of D-phenylserine dehydrogenase, TTHA0237, and PA0743. Similarly, alignment of the amino acid sequence of D-phenylserine dehydrogenase with the sequences of 6-phosphogluconate dehydrogenase from Ovis aries , Saccharomyces cerevisiae , Lactococcus lactis , and Trypanosoma brucei  showed that the GX(G/A)XXG motif and residues interacting with -phosphate group of NADP+ (Gln36 and Arg37) were highly conserved among these enzymes. D-Phenylserine dehydrogenase and these 6-phosphogluconate dehydrogenases prefer NADP+ to NAD+ as a coenzyme. Moreover, a catalytic residue, Lys177, was also conserved in D-phenylserine dehydrogenase, TTHA0237, and PA0743.
The molecular characteristics of L-phenylserine dehydrogenase and D-phenylserine dehydrogenase are summarized in Table 4. The amino acid sequences of these enzymes showed no homology to each other and each enzyme belongs to a different protein family. The amino acid sequence of L-phenylserine dehydrogenase was similar to those of ketoreductase (RED2) from Streptomyces violaceoruber Tü22  and 1,3,8-trihydroxynaphthalene reductase (3HNR) from Magnaporthe grisea [25, 26]. The amino acid sequences of L-phenylserine dehydrogenase and two homologs belonging to the short chain dehydrogenase/reductase (SDR) family aligned well (Figure 4). Members of the SDR family contain a similar structural fold, which shows a common nucleotide-binding site characterized by a GXXXGXG fingerprint motif . Moreover, Arg or Asp residues located 18–20 residues downstream from the motif are responsible for nucleotide specificity [25, 34]. The characteristic glycine-rich fingerprint motif was conserved in the N-terminus of L-phenylserine dehydrogenase. Acidic residues, Asp36 or Asp37, which are 20 and 21 residues downstream, respectively, from the motif probably recognize the -hydroxy group of NAD+. Our kinetic analysis also indicated that L-phenylserine dehydrogenase prefers NAD+ to NADP+ as the coenzyme. An X-ray structure of 3HNR complexed with NADPH and tricyclazole revealed that Ser164, Tyr178, and Lys182 compose the catalytic triad . These residues were highly conserved in L-phenylserine dehydrogenase, RED2, and 3HNR (corresponding to Ser148, Tyr162, and Lys166 in L-phenylserine dehydrogenase) (Figure 4).
Although threonine [14, 35–37], serine [38, 39], and phenylalanine  serve as substrates for many enzymes acting on phenylserine, these amino acids were not accepted as substrates by L-phenylserine dehydrogenase. Among the amino acids tested, L-phenylserine and L-threo-(2-thienyl)serine were good substrates for L-phenylserine dehydrogenase. The genes encoding L-phenylserine dehydrogenase (ORF3) and D-phenylserine dehydrogenase (ORF5) were located within a single operon, and the reaction product of both enzymes is 2-aminoacetophenone. Moreover, D-phenylserine dehydrogenase is induced by addition of DL-threo--phenylserine to a culture medium as a sole source of carbon and nitrogen . Therefore, we consider that D-phenylserine dehydrogenase acts physiologically on D-threo--phenylserine. For these reasons, we assume that the physiological function of L-phenylserine dehydrogenase is an NAD+-dependent conversion of L-phenylserine into 2-aminoacetophenone and carbon dioxide.
The first and the second authors contributed equally to this work.
- R. B. Herbert and B. Wilkinson, “Preparation of (2R, 3S)--hydroxy--amino acids by use of a novel Streptomyces aldolase as a resolving agent for racemic material,” Canadian Journal of Chemistry, vol. 72, pp. 114–117, 1994.
- R. B. Herbert, B. Wilkinson, G. J. Ellames, and E. K. Kunec, “Stereospecific lysis of a range of -hydroxy--amino acids catalysed by a novel aldolase from Streptomyces amakusaensis,” Journal of the Chemical Society, Chemical Communications, no. 2, pp. 205–206, 1993.
- S. D. Jolad, J. J. Hoffmann, S. J. Torrance et al., “Bouvardin and deoxybouvardin, antitumor cyclic hexapeptides from Bouvardia ternifolia (Rubiaceae),” Journal of the American Chemical Society, vol. 99, no. 24, pp. 8040–8044, 1977.
- T. Kimura, V. P. Vassilev, G.-J. Shen, and C.-H. Wong, “Enzymatic synthesis of -hydroxy--amino acids based on recombinant d- and l-threonine aldolases,” Journal of the American Chemical Society, vol. 119, no. 49, pp. 11734–11742, 1997.
- J. Q. Liu, M. Odani, T. Dairi, N. Itoh, S. Shimizu, and H. Yamada, “A new route to l-threo-3-[4-(methylthio)phenylserine], a key intermediate for the synthesis of antibiotics: recombinant low-specificity d-threonine aldolase-catalyzed stereospecific resolution,” Applied Microbiology and Biotechnology, vol. 51, no. 5, pp. 586–591, 1999.
- J. Q. Liu, M. Odani, T. Yasuoka et al., “Gene cloning and overproduction of low-specificity d-threonine aldolase from Alcaligenes xylosoxidans and its application for production of a key intermediate for parkinsonism drug,” Applied Microbiology and Biotechnology, vol. 54, no. 1, pp. 44–51, 2000.
- K. Shibata, K. Shingu, V. P. Vassilev et al., “Kinetic and thermodynamic control of l-threonine aldolase catalyzed reaction and its application to the synthesis of mycestericin D,” Tetrahedron Letters, vol. 37, no. 16, pp. 2791–2794, 1996.
- V. P. Vassilev, T. Uchiyama, T. Kajimoto, and C.-H. Wong, “l-threonine aldolase in organic synthesis: preparation of novel -hydroxy--amino acids,” Tetrahedron Letters, vol. 36, no. 23, pp. 4081–4084, 1995.
- V. P. Vassilev, T. Uchiyama, T. Kajimoto, and C.-H. Wong, “An efficient chemo-enzymatic synthesis of -amino--hydroxy--butyrolactone,” Tetrahedron Letters, vol. 36, no. 28, pp. 5063–5064, 1995.
- W. Maruyama, M. Naoi, and H. Narabayashi, “The metabolism of l-DOPA and l-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients,” Journal of the Neurological Sciences, vol. 139, no. 1, pp. 141–148, 1996.
- R. J. Ulevitch and R. G. Kallen, “Purification and characterization of pyridoxal -phosphate dependent serine hydroxymethylase from lamb liver and its action upon -phenylserines,” Biochemistry, vol. 16, no. 24, pp. 5342–5350, 1977.
- J. Kikuchi, T. Takashima, H. Nakao et al., “Stereoselective synthesis of -phenylserine from glycine and benzaldehyde as mediated by catalytic bilayer membranes, artificial Vitamin -dependent enzymes,” Chemistry Letters, vol. 22, no. 3, pp. 553–556, 1993.
- J. Q. Lui, S. Ito, T. Dairi, N. Itoh, S. Shimizu, and H. Yamada, “Low-specificity l-threonine aldolase of Pseudomonas sp. NCIMB 10558: purification, characterization and its application to -hydroxy--amino acid synthesis,” Applied Microbiology and Biotechnology, vol. 49, no. 6, pp. 702–708, 1998.
- H. Misono, H. Maeda, K. Tuda, S. Ueshima, N. Miyazaki, and S. Nagata, “Characterization of an inducible phenylserine aldolase from Pseudomonas putida 24-1,” Applied and Environmental Microbiology, vol. 71, no. 8, pp. 4602–4609, 2005.
- H. Okuda, S. Nagata, and H. Misono, “Cloning, sequencing, and overexpression in Escherichia coli of a phenylserine dehydratase gene from Ralstonia pickettii PS22,” Bioscience, Biotechnology and Biochemistry, vol. 66, no. 12, pp. 2755–2758, 2002.
- K. Packdibamrung, H. Misono, M. Harada, S. Nagata, and S. Nagasaki, “An inducible -dependent d-phenylserine dehydrogenase from Pseudomonas syringae NK-15: purification and biochemical characterization,” Journal of Biochemistry, vol. 114, no. 6, pp. 930–935, 1993.
- H. Saito and K.-I. Miura, “Preparation of transforming deoxyribonucleic acid by phenol treatment,” Biochimica et Biophysica Acta, vol. 72, pp. 619–629, 1963.
- H. Yamamoto, A. Matsuyama, and Y. Kobayashi, “Synthesis of ethyl ()-4-chloro-3-hydroxybutanoate using fabG-homologues,” Applied Microbiology and Biotechnology, vol. 61, no. 2, pp. 133–139, 2003.
- S. F. Altschul, W. Gish, W. Miller, E. W. Myers, and D. J. Lipman, “Basic local alignment search tool,” Journal of Molecular Biology, vol. 215, no. 3, pp. 403–410, 1990.
- J. D. Thompson, D. G. Higgins, and T. J. Gibson, “CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice,” Nucleic Acids Research, vol. 22, no. 22, pp. 4673–4680, 1994.
- J. A. Wechsler and E. A. Adelberg, “Antipolarity in the ilv operon of Escherichia coli K-12,” Journal of Bacteriology, vol. 98, no. 3, pp. 1179–1194, 1969.
- D. L. Blazey, R. Kim, and R. O. Burns, “Molecular cloning and expression of the ilvGEDAY genes from Salmonella typhimurium,” Journal of Bacteriology, vol. 147, no. 2, pp. 452–462, 1981.
- U. Mäder, S. Hennig, M. Hecker, and G. Homuth, “Transcriptional organization and posttranscriptional regulation of the Bacillus subtilis branched-chain amino acid biosynthesis genes,” Journal of Bacteriology, vol. 186, no. 8, pp. 2240–2252, 2004.
- T. Taguchi, K. Kunieda, M. Takeda-Shitaka et al., “Remarkably different structures and reaction mechanisms of ketoreductases for the opposite stereochemical control in the biosynthesis of BIQ antibiotics,” Bioorganic and Medicinal Chemistry, vol. 12, no. 22, pp. 5917–5927, 2004.
- A. Andersson, D. Jordan, G. Schneider, and Y. Lindqvist, “Crystal structure of the ternary complex of 1,3,8-trihydroxy-naphthalene reductase from Magnaporthe grisea with NADPH and an active-site inhibitor,” Structure, vol. 4, no. 10, pp. 1161–1170, 1996.
- D.-I. Liao, G. S. Basarab, A. A. Gatenby, B. Valent, and D. B. Jordan, “Structures of trihydroxynaphthalene reductase-fungicide complexes: implications for structure-based design and catalysis,” Structure, vol. 9, no. 1, pp. 19–27, 2001.
- H. Fujisawa, S. Nagata, E. K. Chowdhury, M. Matsumoto, and H. Misono, “Cloning and sequencing of the serine dehydrogenase gene from Agrobacterium tumefaciens,” Bioscience, Biotechnology and Biochemistry, vol. 66, no. 5, pp. 1137–1139, 2002.
- N. K. Lokanath, N. Ohshima, K. Takio et al., “Crystal structure of novel NADP-dependent 3-hydroxyisobutyrate dehydrogenase from Thermus thermophilus HB8,” Journal of Molecular Biology, vol. 352, no. 4, pp. 905–917, 2005.
- M. G. Rossmann, D. Moras, and K. W. Olsen, “Chemical and biological evolution of a nucleotide binding protein,” Nature, vol. 250, no. 5463, pp. 194–199, 1974.
- M. J. Adams, G. H. Ellis, S. Gover, C. E. Naylor, and C. Phillips, “Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism,” Structure, vol. 2, no. 7, pp. 651–668, 1994.
- W. He, Y. Wang, W. Liu, and C.-Z. Zhou, “Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1,” BMC Structural Biology, vol. 7, article 38, 2007.
- R. Sundaramoorthy, J. Iulek, M. P. Barrett et al., “Crystal structures of a bacterial B-phosphogluconate dehydrogenase reveal aspects of specificity, mechanism and mode of inhibition by analogues of high-energy reaction intermediates,” FEBS Journal, vol. 274, no. 1, pp. 275–286, 2007.
- C. Phillips, J. Dohnalek, S. Gover, M. P. Barrett, and M. J. Adams, “A 2.8 Å resolution structure of 6-phosphogluconate dehydrogenase from the protozoan parasite Trypanosoma brucei: comparison with the sheep enzyme accounts for differences in activity with coenzyme and substrate analogues,” Journal of Molecular Biology, vol. 282, no. 3, pp. 667–681, 1998.
- N. Tanaka, T. Nonaka, M. Nakanishi, Y. Deyashiki, A. Hara, and Y. Mitsui, “Crystal structure of the ternary complex of mouse lung carbonyl reductase at 1.8 Å resolution: the structural origin of coenzyme specificity in the short-chain dehydrogenase/reductase family,” Structure, vol. 4, no. 1, pp. 33–45, 1996.
- H. Misono, I. Kato, K. Packdibamrung, S. Nagata, and S. Nagasaki, “-dependent d-threonine dehydrogenase from Pseudomonas cruciviae IFO 12047,” Applied and Environmental Microbiology, vol. 59, no. 9, pp. 2963–2968, 1993.
- J.-Q. Liu, S. Ito, T. Dairi et al., “Gene cloning, nucleotide sequencing, and purification and characterization of the low-specificity l-threonine aldolase from Pseudomonas sp. strain NCIMB 10558,” Applied and Environmental Microbiology, vol. 64, no. 2, pp. 549–554, 1998.
- Y. Shimizu, H. Sakuraba, R. Kawakami, S. Goda, Y. Kawarabayasi, and T. Ohshima, “l-Threonine dehydrogenase from the hyperthermophilic archaeon Pyrococcus horikoshii OT3: gene cloning and enzymatic characterization,” Extremophiles, vol. 9, no. 4, pp. 317–324, 2005.
- V. Schirch, S. Hopkins, E. Villar, and S. Angelaccio, “Serine hydroxymethyltransferase from Escherichia coli: purification and properties,” Journal of Bacteriology, vol. 163, no. 1, pp. 1–7, 1985.
- S. Delle Fratte, R. H. White, B. Maras, F. Bossa, and V. Schirch, “Purification and properties of serine hydroxymethyltransferase from Sulfolobus solfataricus,” Journal of Bacteriology, vol. 179, no. 23, pp. 7456–7461, 1997.
- H. Hayashi, K. Inoue, T. Nagata, S. Kuramitsu, and H. Kagamiyama, “Escherichia coli aromatic amino acid aminotransferase: characterization and comparison with aspartate aminotransferase,” Biochemistry, vol. 32, no. 45, pp. 12229–12239, 1993.
Copyright © 2010 Sakuko Ueshima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.